202 related articles for article (PubMed ID: 34436619)
1. Tinea Capitis Caused by Microsporum audouinii: Lessons from a Swedish Community Outbreak.
Calander S; Saunte DML; Polesie S
Acta Derm Venereol; 2021 Sep; 101(9):adv00551. PubMed ID: 34436619
[No Abstract] [Full Text] [Related]
2. Exploring treatment and antifungal resistance in an outbreak of tinea caused by Microsporum audouinii.
Johansen CD; Shen JJR; Astvad KMT; Jemec GBE; Christensen JJ; Saunte DML
Mycoses; 2024 Jul; 67(7):e13760. PubMed ID: 38943042
[TBL] [Abstract][Full Text] [Related]
3. Microsporum audouinii tinea capitis in a Swiss school: assessment and management of patients and asymptomatic carriers.
Donghi D; Hauser V; Bosshard PP
Med Mycol; 2011 Apr; 49(3):324-8. PubMed ID: 20936914
[TBL] [Abstract][Full Text] [Related]
4. Tinea capitis: a current perspective.
Elewski BE
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):1-20; quiz 21-4. PubMed ID: 10607315
[TBL] [Abstract][Full Text] [Related]
5. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long.
Bar J; Samuelov L; Sprecher E; Mashiah J
Mycoses; 2019 Oct; 62(10):949-953. PubMed ID: 31343780
[TBL] [Abstract][Full Text] [Related]
6. Outbreak of tinea capitis by Trichophyton tonsurans and Microsporum canis in Niterói, RJ, Brazil.
Towersey L; Hay RJ; Monteiro MH; Lago MB; Martins Ede C; Estrella RR
Rev Inst Med Trop Sao Paulo; 1992; 34(3):233-8. PubMed ID: 1342076
[TBL] [Abstract][Full Text] [Related]
7. Tinea capitis due to Microsporum audouinii in Malta.
Vella Zahra L; Vella Briffa D
Mycoses; 2003; 46(9-10):433-5. PubMed ID: 14622396
[TBL] [Abstract][Full Text] [Related]
8. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
9. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.
Gits-Muselli M; Benderdouche M; Hamane S; Mingui A; Feuilhade de Chauvin M; Guigue N; Picat MQ; Bourrat E; Petit A; Bagot M; Alanio A; Bretagne S
Med Mycol; 2017 Jul; 55(5):476-484. PubMed ID: 27744309
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
[TBL] [Abstract][Full Text] [Related]
11. [Tinea capitis: clinical features and therapeutic alternatives].
Messina F; Walker L; Romero MLM; Arechavala AI; Negroni R; Depardo R; Marin E; Santiso GM
Rev Argent Microbiol; 2021; 53(4):309-313. PubMed ID: 33618899
[TBL] [Abstract][Full Text] [Related]
12. Tinea capitis in children: a systematic review of management.
Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
[TBL] [Abstract][Full Text] [Related]
13. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
14. New treatments for tinea capitis.
Chan YC; Friedlander SF
Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
[TBL] [Abstract][Full Text] [Related]
15. Tinea capitis in adults.
Aste N; Pau M; Biggio P
Mycoses; 1996; 39(7-8):299-301. PubMed ID: 9009649
[TBL] [Abstract][Full Text] [Related]
16. Tinea capitis.
Gupta AK; Summerbell RC
Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
19. Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.
Kassem R; Barzilai A; Baum S; Kempfner A; Pavlotsky F
Mycoses; 2023 Dec; 66(12):1064-1070. PubMed ID: 37620517
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis.
Gupta AK; Cooper EA; Bowen JE
J Drugs Dermatol; 2008 Apr; 7(4):369-72. PubMed ID: 18459518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
